PTHLH and breast cancer: In human MCF7 breast cancer cells, which normally lie dormant in bone [9, 31–33], overexpression of PTHrP (1-139aa) reprograms the cells to become highly osteolytic and dramatically increases bone tumor burden in vivo [9].